Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids

被引:30
作者
Besancon, Odette G. [1 ]
Tytgat, Godelieve A. M. [2 ]
Meinsma, Rutger [1 ]
Leen, Rene [1 ]
Hoebink, Jerry [1 ]
Kalayda, Ganna V. [3 ]
Jaehde, Ulrich [3 ]
Caron, Huib N. [2 ]
van Kuilenburg, Andre B. P. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Pediat Oncol, Emma Childrens Hosp, NL-1100 DE Amsterdam, Netherlands
[3] Univ Bonn, Inst Pharm, D-53121 Bonn, Germany
关键词
Neuroblastoma; Spheroids; Cisplatin; Gemcitabine; Drug interactions; NUCLEOTIDE EXCISION-REPAIR; PLATINUM-DNA ADDUCT; LUNG-CANCER; PLUS GEMCITABINE; ANTISENSE RNA; PHASE-II; OVARIAN; CYTOTOXICITY; RESISTANCE; THERAPY;
D O I
10.1016/j.canlet.2011.12.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The efficacy and mechanism of action of cisplatin and gemcitabine were investigated in a panel of neuroblastoma cell lines and multicellular tumor spheroids. In neuroblastoma spheroids, the combination of cisplatin and gemcitabine induced a complete cytostasis at clinical relevant concentrations. A synergistic effect was observed when cells were coincubated with both drugs or preincubated with gemcitabine first. These administration sequences resulted in NASS cells in decreased ERCC1 and XPA expression, two key proteins of the NER DNA repair system, and increased platinum adduct formation in DNA. Most of these phenomena were not observed in SJNB8 cells which might explain the lack of synergy between cisplatin and gemcitabine in SJNB8 cells. Our results showed favorable interactions between cisplatin and gemcitabine in 4 out of 5 cell lines. Therefore, we feel that inclusion of gemcitabine into cisplatin-containing regiments might be a promising new strategy for the treatment of neuroblastoma. (c) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 36 条
[1]   Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma [J].
Bierau, J ;
van Gennip, AH ;
Leen, R ;
Meinsma, R ;
Caron, HN ;
van Kuilenburg, ABP .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (01) :105-113
[2]   Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity [J].
Bierau, J ;
van Gennip, AH ;
Leen, R ;
Helleman, J ;
Caron, HN ;
van Kuilenburg, ABP .
INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (03) :387-392
[3]   Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells [J].
Blair, Brian G. ;
Larson, Christopher A. ;
Adams, Preston L. ;
Abada, Paolo B. ;
Safaei, Roohangiz ;
Howell, Stephen B. .
MOLECULAR PHARMACOLOGY, 2010, 77 (06) :912-921
[4]   Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].
Burris, HA ;
Moore, MJ ;
Andersen, J ;
Green, MR ;
Rothenberg, ML ;
Madiano, MR ;
Cripps, MC ;
Portenoy, RK ;
Storniolo, AM ;
Tarassoff, P ;
Nelson, R ;
Dorr, FA ;
Stephens, CD ;
VanHoff, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413
[5]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[6]  
Cuperus R, 2008, INT J ONCOL, V32, P1011
[7]   MycN sensitizes neuroblastoma cells for drug-induced apoptosis [J].
Fulda, S ;
Lutz, W ;
Schwab, M ;
Debatin, KM .
ONCOGENE, 1999, 18 (07) :1479-1486
[8]   Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport [J].
Furukawa, Tatsuhiko ;
Komatsu, Masaharu ;
Ikeda, Ryuji ;
Tsujikawa, Kazutake ;
Akiyama, Shin-ichi .
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (30) :3268-3278
[9]   Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study [J].
Geoerger, Birgit ;
Chisholm, Julia ;
Le Deley, Marie-Cecile ;
Gentet, Jean-Claude ;
Zwaan, Christian Michel ;
Dias, Nathalie ;
Jaspan, Timothy ;
Mc Hugh, Kieran ;
Couanet, Dominique ;
Hain, Sharon ;
Devos, Annick ;
Riccardi, Riccardo ;
Cesare, Colosimo ;
Boos, Joachim ;
Frappaz, Didier ;
Leblond, Pierre ;
Aerts, Isabelle ;
Vassal, Gilles .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (02) :230-238
[10]  
HEINEMANN V, 1990, MOL PHARMACOL, V38, P567